Danaher Corporation (NYSE:DHR) Shares Bought by Horizon Financial Services LLC

Horizon Financial Services LLC lifted its holdings in shares of Danaher Corporation (NYSE:DHR) by 20,400.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,200 shares of the conglomerate’s stock after buying an additional 8,160 shares during the quarter. Horizon Financial Services LLC’s holdings in Danaher were worth $1,681,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in DHR. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth $27,000. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher in the 1st quarter valued at approximately $31,000. Rialto Wealth Management LLC purchased a new position in Danaher during the fourth quarter worth about $34,000. Finally, Hurley Capital LLC purchased a new position in shares of Danaher during the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is owned by company insiders.

Danaher Stock Performance

NYSE DHR opened at $202.13 on Wednesday. The business has a 50 day moving average price of $195.27 and a 200 day moving average price of $207.84. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05. The company has a market capitalization of $144.66 billion, a P/E ratio of 39.20, a PEG ratio of 2.77 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.63%. Danaher’s dividend payout ratio is currently 24.85%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft decreased their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research note on Friday, March 14th. Wolfe Research cut their price objective on shares of Danaher from $275.00 to $220.00 and set an “outperform” rating on the stock in a report on Monday, April 7th. Evercore ISI cut their target price on Danaher from $240.00 to $230.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 22nd. Finally, Bank of America dropped their price target on Danaher from $265.00 to $230.00 in a research note on Monday, April 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $248.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.